Pharming Group N.V.

PHARM.AS · AMS
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income€13€7-€12€7
Dep. & Amort.€3€3€3€8
Deferred Tax€0€0€0€0
Stock-Based Comp.€3€3€3€3
Change in WC€11-€1€1-€7
Other Non-Cash€2-€0€5-€1
Operating Cash Flow€32€12€0€9
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions-€0-€0-€58€0
Inv. Purchases€0€0€0-€62
Inv. Sales/Matur.€0€17€68€52
Other Inv. Act.€0€0€0€0
Investing Cash Flow-€0€17€10-€10
Financing Activities
Debt Repay.-€1-€1-€1-€2
Stock Issued€0€0€0€0
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.€11-€2-€6-€1
Financing Cash Flow€10-€3-€7-€2
Forex Effect-€1€6€2-€3
Net Chg. in Cash€40€32€5-€6
Supplemental Information
Beg. Cash€92€60€55€61
End Cash€132€92€60€55
Free Cash Flow€32€12-€0€9